Miquel Vila-Perello, Ph.D.

Miquel Vila-Perello, Ph.D.,  Co-Founder and CEO of SpliceBio, a gene therapy company based in Barcelona that he has led since its inception in 2014. Under his leadership, SpliceBio has grown from an early-stage concept into a global clinical-stage biotechnology company, advancing multiple programs into development—including the lead program for Stargardt disease currently in the clinic—and securing over $200 million in funding from top-tier investors.